1 week Ago By ABMN Staff
National Bank of Canada FI lifted its stake in shares of Agilent Technologies, Inc. ( NYSE:A – Free Report ) by 24.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
The institutional investor owned 80,830 shares of the medical research company’s stock after purchasing an additional 15,872 shares during the quarter. National Bank of Canada FI’s holdings in Agilent Technologies were worth $10,298,000 at the end of the most recent reporting period. Several other hedge funds and other institutional investors have also recently bought and sold shares of the business.
Consolidated Planning Corp bought a new stake in Agilent Technologies in the second quarter worth about $268,000. Larson Financial Group LLC raised its position in Agilent Technologies by 945.6% in the second quarter.
Larson Financial Group LLC now owns 3,074 shares of the medical research company’s stock worth $398,000 after acquiring an additional 2,780 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in Agilent Technologies by 0.4% in the second quarter.
Oregon Public Employees Retirement Fund now owns 25,180 shares of the medical research company’s stock worth $3,264,000 after acquiring an additional 100 shares in the last quarter. FFT Wealth Management LLC purchased a new position in Agilent Technologies in the 2nd quarter worth about $261,000. Finally, Natixis Advisors LLC increased its stake in Agilent Technologies by 15.
2% in the 2nd quarter. Natixis Advisors LLC now owns 98,556 shares of the medical research company’s stock worth $12,775,000 after purchasing an additional 13,003 shares in the last quarter. 87.
42% of the stock is currently owned by institutional investors. Wall Street Analysts Forecast Growth A number of equities analysts recently weighed in on the company. Stifel Nicolaus reissued a “buy” rating and issued a $151.
00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Bank of America lifted their price target on Agilent Technologies from $140.00 to $147.
00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Evercore ISI lifted their price target on Agilent Technologies from $130.00 to $135.
00 and gave the stock an “in-line” rating in a research note on Thursday, August 22nd. Robert W. Baird dropped their price target on Agilent Technologies from $147.
00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. Finally, Wolfe Research cut Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th.
One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $141.60.
Agilent Technologies Stock Down 0.8 % A opened at $137.20 on Monday.
The firm has a market cap of $40.03 billion, a P/E ratio of 32.43, a price-to-earnings-growth ratio of 6.
63 and a beta of 1.05. The company has a debt-to-equity ratio of 0.
36, a quick ratio of 1.37 and a current ratio of 1.78.
The business has a 50 day moving average price of $135.62 and a 200 day moving average price of $139.08.
Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.
35. Agilent Technologies ( NYSE:A – Get Free Report ) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.
32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06.
The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion.
Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%.
Agilent Technologies’s revenue was down 5.6% compared to the same quarter last year. During the same period last year, the business posted $1.
43 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.
24 EPS for the current year. Insider Transactions at Agilent Technologies In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.
00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares in the company, valued at $3,497,110.
The sale was disclosed in a filing with the SEC, which can be accessed through this link . 0.33% of the stock is currently owned by corporate insiders.
Agilent Technologies Company Profile ( Free Report ) Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter ..
